We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$17.8B
AUM Growth
+$1.56B
(+9.6%)
Cap. Flow
+$1.29B
Cap. Flow
% of AUM
7.26%
Top 10 Holdings %
Top 10 Hldgs %
44.67%
Holding
3,394
New
1,168
Increased
565
Reduced
380
Closed
1,233
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$218M |
| 2 |
Super Micro Computer
SMCI
|
+$199M |
| 3 |
Apple
AAPL
|
+$185M |
| 4 |
Amazon
AMZN
|
+$174M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.3B |
| 2 |
Merck
MRK
|
+$203M |
| 3 |
Workday
WDAY
|
+$178M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$176M |
| 5 |
CRH
CRH
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Industrials | 7.93% |
| 3 | Consumer Discretionary | 7.91% |
| 4 | Financials | 7.65% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Cato Corp
CATO
$65.9M
| $130K | ﹤0.01% |
+23,476
| New | +$126K |
|
1727
Liquidia Corp
LQDA
$7.95B
| $130K | ﹤0.01% |
+10,886
| New | +$145K |
|
|
NVX
1728
NOVONIX
NVX
$101M
| $130K | ﹤0.01% |
+72,810
| New | +$163K |
|
1729
Incannex Healthcare
IXHL
$37.2M
| $129K | ﹤0.01% |
1,464
-1,302
| -47% | -$112K |
|
1730
Karyopharm Therapeutics
KPTI
$44.2M
| $128K | ﹤0.01% |
+9,836
| New | +$163K |
|
|
ARIS
1731
Aris Mining
ARIS
$3.25B
| $127K | ﹤0.01% |
+34,008
| New | +$137K |
|
|
AWF
1732
AllianceBernstein Global High Income Fund
AWF
$872M
| $127K | ﹤0.01% |
+12,165
| New | +$128K |
|
1733
Melco Resorts & Entertainment
MLCO
$2.14B
| $127K | ﹤0.01% |
+17,115
| New | +$129K |
|
|
TEF
1734
DELISTED
Telefonica
TEF
| $126K | ﹤0.01% |
+30,111
| New | +$133K |
|
1735
Televisa
TV
$1.5B
| $125K | ﹤0.01% |
+45,256
| New | +$139K |
|
|
OLO
1736
DELISTED
Olo Inc
OLO
| $124K | ﹤0.01% |
28,135
-18,866
| -40% | -$89.3K |
|
1737
Compass Therapeutics
CMPX
$358M
| $122K | ﹤0.01% |
+122,038
| New | +$178K |
|
1738
inTEST
INTT
$180M
| $121K | ﹤0.01% |
+12,312
| New | +$132K |
|
1739
James River Group Holdings
JRVR
$221M
| $121K | ﹤0.01% |
15,736
-28,926
| -65% | -$238K |
|
|
CUTR
1740
DELISTED
Cutera, Inc.
CUTR
| $119K | ﹤0.01% |
+79,196
| New | +$159K |
|
|
ALFUU
1741
Centurion Acquisition Corp Unit
ALFUU
| $116K | ﹤0.01% |
+11,613
| New | +$116K |
|
|
EVN
1742
Eaton Vance Municipal Income Trust
EVN
$421M
| $115K | ﹤0.01% |
+11,131
| New | +$112K |
|
1743
2x Long VIX Futures ETF
UVIX
$196M
| $115K | ﹤0.01% |
103
-291
| -74% | -$448K |
|
|
OMGA
1744
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $115K | ﹤0.01% |
+55,847
| New | +$132K |
|
1745
Bumble
BMBL
$372M
| $114K | ﹤0.01% |
+10,921
| New | +$119K |
|
|
UROY
1746
Uranium Royalty Corp
UROY
$1.51B
| $114K | ﹤0.01% |
+50,911
| New | +$126K |
|
1747
Adeia
ADEA
$3.12B
| $112K | ﹤0.01% |
+10,096
| New | +$110K |
|
1748
PDS Biotechnology
PDSB
$41.8M
| $111K | ﹤0.01% |
+38,107
| New | +$122K |
|
|
PNNT
1749
Pennant Park Investment Corp
PNNT
$236M
| $110K | ﹤0.01% |
14,600
-54,146
| -79% | -$393K |
|
1750
Nomura Holdings
NMR
$29B
| $109K | ﹤0.01% |
+18,915
| New | +$112K |
|
Similar funds
DB
HRT Financial's Q2 2024 Portfolio in Review
As of Q2 2024, HRT Financial held 3,394 positions worth $17.8B, up 9.6% from $16.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
HRT Financial deployed $1.29B of net new capital in Q2 2024, opening 1,168 new positions and adding to 565 existing holdings. Its largest new stake was ExxonMobil: 1,873,568 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.5% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.
- HRT Financial's largest Q2 2024 buy was ExxonMobil: 1,873,568 shares worth $216M.
- HRT Financial added most to Apple in Q2 2024, an estimated $185M increase.
- HRT Financial's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
- HRT Financial fully exited Merck in Q2 2024, selling an estimated $203M.
- HRT Financial's ten largest holdings make up 45% of its $17.8B portfolio in Q2 2024.
- HRT Financial opened 1,168 new positions and closed 1,233 in Q2 2024.
- HRT Financial's portfolio value rose 9.6% quarter-over-quarter to $17.8B.
Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.